Showing 1001-1010 of 21418 results for "".
- Semaglutide: Cardiovascular Protection in High-Risk Obesityhttps://reachmd.com/news/semaglutide-cardiovascular-protection-in-high-risk-obesity/2474611/The SELECT trial provides compelling evidence that semaglutide offers early cardiovascular protection in overweight or obese patients with pre-existing heart disease, even without the presence of diabetes. These findings highlight semaglutide's
- Common Medications: Delaying Symptom Onset in Parkinson's Diseasehttps://reachmd.com/news/common-medications-delaying-symptom-onset-in-parkinsons-disease/2474120/Recent findings from Cedars-Sinai reveal that medications frequently prescribed for pain, blood pressure, diabetes, and cholesterol management may correlate with a delayed onset of Parkinson's disease symptoms. This discove
- Enhancing Chronic Condition Management Through Coordinated Primary Care Teamshttps://reachmd.com/news/enhancing-chronic-condition-management-through-coordinated-primary-care-teams/2473996/As chronic conditions such as diabetes, hypertension, and heart disease continue to strain healthcare systems, a growing body of evidence points to a straightforward yet transformative solution: coordinated primary care teams. These structured teams are proving cri
- Sleep Profiles and Suicidal Ideation in Psychiatric Outpatientshttps://reachmd.com/news/sleep-profiles-and-suicidal-ideation-in-psychiatric-outpatients/2488778/Key Takeaways Among adult outpatients with sleep complaints at a psychiatric specialist hospital in China, the Mild Disturbance, Severe Insomnia, and Moderate Non-Medicated profiles had elevated adjusted odds of active suicidal ideation. The Moderate Non-Medicated pr
- HBV Birth-Dose Alternatives Linked to More Infections in Modelhttps://reachmd.com/news/hbv-birth-dose-alternatives-linked-to-more-infections-in-model/2488761/Key Takeaways In a modeled US infant birth cohort, shared decision-making about hepatitis B vaccination projected 83% more childhood chronic HBV infections than universal birth-dose vaccination. Deferring vaccination until age 2 months projected 19% more childhood ch
- FDA Clears IND for Phase 2 Trial of Injectable rhPDGF-BB for Infraorbital Hollowinghttps://reachmd.com/news/fda-clears-ind-for-phase-2-trial-of-injectable-rhpdgf-bb-for-infraorbital-hollowing/2488767/Lynch Regenerative Medicine (LRM) announced that the US Food and Drug Administration (FDA) has authorized its Investigational New Drug (IND) application for a Phase 2 clinical trial evaluating injectable recombinant human platelet-derived growth factor-BB (rhPDGF-BB) for the treatment of infraorb
- RDW-to-Albumin Ratio Linked to IgA Nephropathy Outcomeshttps://reachmd.com/news/rdw-albumin-ratio-iga-nephropathy-outcomes/2488753/Key Takeaways Among patients with biopsy-proven IgA nephropathy at West China Hospital in China, higher baseline RAR was significantly associated with the renal composite after adjustment and matching. RAR discriminated the endpoint better than either constituent mea
- Study: Acupressure Improves Rosacea Severity, Reduces Inflammatory Biomarkershttps://reachmd.com/news/study-acupressure-improves-rosacea-severity-reduces-inflammatory-biomarkers/2488756/Device-free auricular acupressure improved clinical outcomes and reduced inflammatory biomarkers in patients with rosacea receiving standard first-line treatment, according to findings from a trial published in JAMA Dermatology. The randomized, single-center, sham-controlled, asse
- TRICYCLE: Triple Vasopressors Improve Septic Shock Markershttps://reachmd.com/news/tricycle-triple-vasopressors-improve-septic-shock-markers/2488738/Key Takeaways In the TRICYCLE trial of adults with septic shock requiring vasopressors, starting angiotensin II, vasopressin, and norepinephrine together produced a significantly faster decline in plasma renin than stepwise escalation. Concurrent treat
- Fall Clinical Talk Highlights KIT Inhibition's Promise for Chronic Spontaneous Urticariahttps://reachmd.com/news/fall-clinical-talk-highlights-kit-inhibitions-promise-for-chronic-spontaneous-urticaria/2488733/Emerging evidence supports KIT inhibition as a novel therapeutic approach, Naiem Issa, MD, PhD, FAAD, said in a talk at the 2026 Fall Clinical Dermatology Conference. Targeting the KIT signaling pathway may offer a new treatment strategy for patients with chronic spontaneous urticaria (CSU